Lyell Immunopharma (LYEL) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,063.00+0.60%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Lyell Immunopharma Inc (LYEL) Stock Price, Quote, News & History

LYELNASDAQ

Trade with Public

Trade with Public

$8.71

-0.08-0.91%

Last update: Oct 9, 4:00 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$8.72

Close

$8.71

Volume / Avg.

106.45K / 147.49K

Day Range

$8.71 - $8.71

52 Wk Range

8.21 - 45.00

Market Cap

$215.40M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

25

Short Interest

6.02%

Days to Cover

7.4

Recent Lyell Immunopharma, Inc. News

This Lyell Immunopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday

Wall Street analysts change outlook on top names. Check analyst ratings page for all changes. See what analysts say about LYEL, IMRX, and RNA.

Avi Kapoor

Lyell Immunopharma Issues Colorectal Cancer Drug Safety Update

Lyell Immunopharma reports improved safety data for LYL273 in metastatic colorectal cancer and advances study to Phase 1/2 design.

Vandana Singh

This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Wall Street analysts changed outlook on top stocks. See rating changes on NKE, SMPL, WSR, NTNX, and AES. Check analyst views before buying NKE.

Avi Kapoor

This WhiteFiber Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

Top Wall Street analysts changed outlook on top names. Initiations & upgrades noted. For full changes, see analyst ratings page.

Avi Kapoor

This Eaton Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-133.26M

Investing Cash Flow (TTM)

4.98M

Financing Cash Flow (TTM)

102.47M

Free Cash Flow (TTM)

-133.97M

Capital Expenditure (TTM)

-711.00K

Net Change in Cash (TTM)

-25.82M

Analyst Trends and Forecast

1

May

4

Jun

1

Jul

1

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$46.15M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

6834.74

PB Ratio (TTM)

0.92

Earnings Yield % (TTM)

-144.53%

Earnings Yield % (FWD)

-111.16%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$9.54

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$72.99M

Debt to Equity

0.16

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-